ID   L-bFGF-5
AC   CVCL_A9DW
DR   CCRID; 4201PAT-CCTCC00013
DR   Wikidata; Q108820641
RX   Patent=EP0237966A2;
CC   Group: Patented cell line.
CC   Registration: Non-internationally recognized Depositary Authority, Institute for Fermentation, Osaka; IFO50092.
CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transfected with: HGNC; 3676; FGF2.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 5
//
RX   Patent=EP0237966A2;
RA   Kurokawa T., Sasada R., Iwane M., Igarashi K.;
RT   "Human basic fibroblast growth factor.";
RL   Patent number EP0237966A2, 16-Mar-1988.
//